September 15 -18, 2025
Hynes Convention CenterBoston, USA Shu WangPrincipal Investigator at IncyteSpeaker
Profile
Dr. Shu Wang is a Principal Investigator at Incyte with over 20 years of experience in cell culture. He holds a Ph.D. in Genetics and has completed postdoctoral training in prestigious laboratories. Transitioning to industry, Dr. Wang specializes in cell line development, covering the entire process from transfection to MCB release. He has filed IND and IMPD applications for therapeutic antibodies, some of which are in clinical trials. Dr. Wang optimizes cell line development procedures and collaborates on Beacon on-chip binding assays to enhance bispecific antibody production, aiming to streamline development and improve quality.
Agenda Sessions
Development of an on-chip binding assay to select clones expressing high quality bispecific antibodies
, 11:50amView Session